| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |